Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

NIKOLIC, Dragana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.145
EU - Europa 3.126
AS - Asia 2.573
SA - Sud America 513
Continente sconosciuto - Info sul continente non disponibili 435
AF - Africa 74
OC - Oceania 13
Totale 13.879
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.034
IT - Italia 988
SG - Singapore 920
RU - Federazione Russa 829
CN - Cina 701
BR - Brasile 405
FI - Finlandia 280
VN - Vietnam 258
HK - Hong Kong 248
PL - Polonia 178
GB - Regno Unito 155
DE - Germania 147
FR - Francia 139
IE - Irlanda 135
JP - Giappone 83
IN - India 67
BD - Bangladesh 59
UA - Ucraina 59
KR - Corea 55
CA - Canada 52
SE - Svezia 41
NL - Olanda 40
RO - Romania 37
AR - Argentina 34
MX - Messico 28
TR - Turchia 22
IQ - Iraq 20
AT - Austria 19
CI - Costa d'Avorio 18
UZ - Uzbekistan 17
CO - Colombia 16
IR - Iran 15
ZA - Sudafrica 15
PY - Paraguay 14
BE - Belgio 13
ES - Italia 13
MY - Malesia 13
ID - Indonesia 12
CL - Cile 11
PK - Pakistan 11
AU - Australia 10
CZ - Repubblica Ceca 10
EC - Ecuador 10
KE - Kenya 10
MA - Marocco 10
NP - Nepal 10
VE - Venezuela 10
PH - Filippine 9
GR - Grecia 8
SA - Arabia Saudita 8
CH - Svizzera 7
HN - Honduras 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BG - Bulgaria 5
CR - Costa Rica 5
DK - Danimarca 5
HU - Ungheria 5
IL - Israele 5
JO - Giordania 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
KZ - Kazakistan 4
LB - Libano 4
TN - Tunisia 4
AZ - Azerbaigian 3
EG - Egitto 3
GT - Guatemala 3
NZ - Nuova Zelanda 3
PE - Perù 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GY - Guiana 2
HR - Croazia 2
JM - Giamaica 2
MD - Moldavia 2
PS - Palestinian Territory 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BW - Botswana 1
BZ - Belize 1
CV - Capo Verde 1
GH - Ghana 1
GM - Gambi 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LT - Lituania 1
LY - Libia 1
Totale 13.442
Salva come PNG Salva come JPEG
Città #
Fairfield 966
Ashburn 798
Singapore 610
Woodbridge 413
Chandler 386
Seattle 377
Houston 369
San Jose 369
Wilmington 363
Cambridge 333
Hong Kong 238
Ann Arbor 192
Palermo 180
Zgierz 159
Moscow 149
Dublin 135
Beijing 130
Medford 119
Santa Clara 107
Des Moines 99
Altamura 93
Los Angeles 89
Dallas 86
Ho Chi Minh City 86
Council Bluffs 77
Helsinki 77
Tokyo 76
Princeton 75
New York 74
Lauterbourg 68
Lawrence 68
Nanjing 67
Rome 53
San Diego 53
Hanoi 52
Boardman 51
Chicago 40
São Paulo 40
Dearborn 39
Frankfurt am Main 39
Milan 39
Changsha 33
London 33
Jinan 32
Buffalo 31
Nanchang 31
Columbus 30
The Dalles 30
Hebei 27
Shenyang 27
Jacksonville 25
Nuremberg 24
Hefei 23
Tianjin 23
Phoenix 22
Orem 20
Abidjan 18
Tulsa 18
Zhengzhou 17
Atlanta 15
Naples 15
Turin 15
Amsterdam 14
Ludwigshafen am Rhein 14
Ningbo 14
Pune 14
Rio de Janeiro 14
Haiphong 13
Jiaxing 13
Munich 13
Toronto 13
Bologna 12
Brooklyn 12
Guangzhou 12
Montreal 12
Boston 11
Brussels 11
Da Nang 11
Redwood City 11
San Francisco 11
San Paolo di Civitate 11
Taizhou 11
Tashkent 11
Vienna 11
Warsaw 11
Baghdad 10
Brno 10
Falls Church 10
Florence 10
Napoli 10
Paris 10
Saint Petersburg 10
Tehran 10
Belo Horizonte 9
Bogotá 9
Denver 9
Nairobi 9
Asunción 8
Auburn Hills 8
Bangalore 8
Totale 8.763
Salva come PNG Salva come JPEG
Nome #
LE VESCICOLE EXTRACELLULARI VEGETALI PER LO SVILUPPO DI NUOVI NUTRACEUTICI: STUDIO PRE-CLINICO E CLINICO DELLE PROPRIETÀ BIOLOGICHE DELLE VESCICOLE ISOLATE DA SUCCO DI LIMONE 454
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 319
The dissociation of the Hsp60/pro-Caspase-3 complex by bis(pyridyl)oxadiazole copper complex (CubipyOXA) leads to cell death in NCI-H292 cancer cells 279
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 261
The Role of Nutraceuticals in Statin Intolerant Patients 256
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 249
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 246
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 245
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. 234
Serum low density lipoprotein subclasses in asthma 232
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 232
A novel copper compound, CuNV110, induces apoptosis in tumor cells by dissociation of the Hsp60-pro-caspase 3 complex 230
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease 228
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 222
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 222
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 218
Management of Statin Intolerance in 2018: Still More Questions Than Answers 217
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? 202
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 202
Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases 200
Statin intolerance - An attempt at a unified definition. Position paper from an International Lipid Expert Panel 200
Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. 199
The effect of bergamot on dyslipidemia 194
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 192
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 190
Anti-cytokine therapy for prevention of atherosclerosis 189
Should low high-density lipoprotein cholesterol (HDL-C) be treated? 187
Emerging approaches for the treatment of hypertriglyceridemia. 186
Effects of aging and diet on cardioprotection and cardiometabolic risk markers 184
Anti-inflammatory properties of an aldehydes-enriched fraction of grapefruit essential oil 182
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease 180
GLP-1 receptor agonists, carotid atherosclerosis and retinopathy 179
Resistin: An inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome 177
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 176
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. 176
An evaluation of RVX-208 for the treatment of atherosclerosis 175
Statin intolerance-an attempt at a unified definition. Position paper from an International Lipid Expert Panel 175
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. 173
CuNV1110 induces dissociation of the Hsp60-pro-caspase 3 complex and activation of apoptosis in tumor cells 172
Nutraceuticals as an important part of combination therapy in dyslipidaemia 170
An overview of statin-induced myopathy and perspectives for the future 170
Preliminary results of citraves™ effects on low density lipoprotein cholesterol and waist circumference in healthy subjects after 12 weeks: A pilot open-label study 170
Uric acid metabolism in pre-hypertension and the metabolic syndrome 169
The role of fibrate treatment in dyslipidemia: an overview. 167
SUBFRACTIONS AND SUBPOPULATIONS OF HDL: AN UPDATE 167
Periodontitis, blood lipids and lipoproteins 165
Serum lipoproteins are not associated with the severity of asthma 163
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. 162
Exosomal Heat Shock Proteins as a New Players in Tumor Cell-to-Cell Comunication 159
Effects of Liraglutide on Metabolic Parameters and Carotid Intima-Media Thickness in Patients with The Metabolic Syndrome: A 12-Month Prospective Pilot Study 156
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes 150
INCRETIN-BASED THERAPIES, GLUCOMETABOLIC HEALTH AND ENDOVASCULAR INFLAMMATION 149
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms 148
Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study 147
Serological, immunomorphological and bioinformatics analyses suggest Hsp60 is involved in Hashimoto’s thyroiditis pathogenesis. 142
STATINS AND NEW-ONSET DIABETES 139
Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins Be Key Mediators Of This Association? 136
Natural approaches in metabolic syndrome management 134
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 134
Incretins, pregnancy, and gestational diabetes 133
Choosing an ideal pharmacotherapeutic strategy for dyslipidemia in children 131
Intensive LDL-cholesterol lowering therapy and neurocognitive function 129
A multicomponent personalized prevention program in the primary care setting: a randomized clinical trial in older people with noncommunicable chronic diseases (Primacare_P3 study) 127
Statin treatment in the elderly: how much do we know? 119
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan 116
Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors 116
Gut microbiota, obesity and bariatric surgery: Current knowledge and future perspectives 115
Peroxisome proliferator-activated receptors and atherosclerosis 113
Lifestyle recommendations for the prevention and management of metabolic syndrome: An international panel recommendation 109
PPAR agonists, atherogenic dyslipidemia and cardiovascular risk 108
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 107
Nutraceuticals as lipid-lowering treatment in pregnancy and their effects on the metabolic syndrome 106
IMPROVE-IT: What have we learned? 102
LIPOPROTEIN SUBCLASS DISTRIBUTION IN DIFFERENT CLINICAL PATTERNS AND THEIR VARIATION AFTER THERAPY 95
ETC-1002: A future option for lipid disorders? 95
Small, dense LDL: An update 94
Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia 91
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 85
Psoriasis and acute coronary syndrome risk 82
Novel anti-obesity drugs and plasma lipids 62
null 61
Weight loss programmes using low carbohydrate diets to control the cardiovascular risk in adolescents (Review) 52
Totale 13.879
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.045
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022850 0 135 32 23 22 63 28 72 104 160 45 166
2022/20231.296 142 253 21 121 130 187 112 104 138 12 55 21
2023/2024588 39 83 77 22 45 106 44 50 12 28 20 62
2024/20251.581 45 171 176 145 57 56 74 85 131 165 159 317
2025/20264.446 329 165 250 387 443 587 586 507 380 384 196 232
2026/2027391 325 66 0 0 0 0 0 0 0 0 0 0
Totale 13.879